CVS Caremark's latest formulary changes are poised to strengthen GLP-1 Medication Access for commercial plan members by restoring coverage for select weight-management therapies. Effective October 1, 2026, Zepbound returns as a preferred option on template formularies for sponsors that elect c...

Contemporary comparative effectiveness research plays a vital role in supporting federal and state drug pricing programs by highlighting real-world benefits, yet persistent challenges and unclear guidance continue to limit its integration. Core principles of evidence evaluation, research question...

European pharmacists preparation ensures that community networks remain operational during health crises, enabling continuous patient care amid pandemics and infrastructure failures. The recently published PGEU position paper outlines seven priorities that integrate pharmacies into governance str...

The Imfinzi bladder cancer approval by the FDA now offers a new immunotherapy option for adults with BCG-naïve, high-risk non-muscle-invasive bladder cancer when combined with standard BCG induction and maintenance therapy. This Imfinzi bladder cancer approval stems from the POTOMAC Phase III ...

Radioligand Therapy Prostate Cancer has emerged as a breakthrough approach in prostate cancer treatment by linking a cancer-targeting molecule to a radioactive payload that delivers radiation directly to tumor cells. This method minimizes damage to nearby healthy tissue while demonstrating clinic...

Conversational Agent Interventions demonstrate measurable benefits for mental health, according to a meta-analysis of 48 randomized controlled trials involving 28,071 participants that found both AI-based and rule-based agents produced small-to-moderate reductions in depression (SMD −0.27), anxie...